Optiray 350 741 mg/mL

Optiray 350 741 mg/mL is a radiopaque contrast medium used for diagnostic imaging procedures. This injection, containing ioversol, aids in enhancing visibility during imaging to improve diagnostic accuracy.

Optiray 350 741 mg/mL is primarily used as a contrast agent in medical imaging. It is administered intravenously or intra-arterially to enhance the visibility of blood vessels and organs. This helps healthcare professionals obtain clearer images for better diagnosis. Optiray 350 is often used in procedures like angiography and computed tomography (CT) scans.

When administered, Optiray 350 741 mg/mL may cause a temporary warm sensation or a metallic taste in the mouth. Some individuals might experience mild discomfort at the injection site. These effects are generally short-lived and subside quickly.

Optiray 350 741 mg/mL should be used with caution in individuals with known allergies to contrast media. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the solution.

Optiray 350 741 mg/mL may interact with certain medications, particularly those that affect kidney function. It is advisable to consult with a healthcare provider regarding potential interactions with other medications. Alcohol and other substances that affect kidney function should be avoided.